Allelic imbalance and mutations of the PTEN gene in ovarian cancer

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 160-165

  Saito, Misato ^a   Okamoto, Aikou ^a   Kohno, Takashi ^b   Takakura, Satoshi ^a,b   Shinozaki, Hideo ^a   Isonishi, Seiji ^a   Yasuhara, Takaomi ^c   Yoshimura, Tomoaki ^c   Ohtake, Yasuyuki ^c   Ochiai, Kazunori ^a   Yokota, Jun ^b   Tanaka, Tadao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c ASAHI BREWERIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ARTICLE; CHROMOSOME 10Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCATION; GENE STRUCTURE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MARKER GENE; MICROSATELLITE INSTABILITY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0034650817     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<160::AID-IJC2>3.3.CO;2-X     Document Type: Article

References (31)

1. CAIRNS, P., OKAMI, K., HALACHMI, S., HALACHMI, N., ESTELLER, M., HERMAN, J.G., ISAACS, W.B., BOVA, G.S. and SIDRANSKY, D., Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000 (1997).
2. CHENEY, I.W., JOHNSON, D.E., VAILLANCOURT, M.T., AVANZINI, J., MORIMOTO, A., DEMERS, G.W., WILLS, K.M., SHABRAM, P.W., BOLEN, J.B., TAVTIGIAN, S.V. and BOOKSTEIN, R., Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res., 58, 2331-2334 (1998).
3. CRISTOFANO, A.D., PESCE, B., CORDON-CARDO, C. and PANDOLFI, P.P., Pten is essential for embryonic development and tumor suppression. Nature (Genet.). 19, 348-355 (1998).
4. DAHIA, P.L.M., MARSH, D.J., ZHENG, Z., ZEDENIUS, J., KOMMINOTH, P., FRISK, T., WALLIN, G., PARSONS, R., LONGY, M., LARSSON, C. and ENG, C., Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res., 57, 4710-4713 (1997).
5. FU, X.Y., GE, H. and MANLEY, J.L., The role of the polypymidine stretch at the SV40 early pre-mRNA 3' splice site in alternative splicing. EMBO J., 7, 809-817 (1988).
6. KOHNO, T., TAKAHASHI, M., FUKUTOMI, T., USHIO, K. and YOKOTA, J., Germline mutations of the PTEN/MMAC1 gene in Japanese patients with Cowden disease. Jpn. J. Cancer Res., 89, 471-474 (1998a).
7. KOHNO, T., TAKAHASHI, M., MANDA, R. and YOKOTA, J., Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancer. Genes Chromosomes Cancer, 22, 152-156 (1998b).
8. KONG, D. AND 18 OTHERS, PTEN is frequently mutated in primary endometrial carcinomas. Nature (Genet.), 17, 143-144 (1997).
9. LEVINE, R.L., CARGILE, C.B., BLAZES, M.S., VAN REES, B., KURMAN, R.J. and ELLENSON, L.H., PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res., 58, 3254-3258 (1998).
10. LI, D-M. and SUN, H., TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57, 2124-2129 (1997).
11. LI, J. AND 16 OTHERS, PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
12. LIAW, D., MARSH, D.J., LI, J., DAHIA, P.L.M., WANG, S.I., ZHENG, Z., BOSE, S., CALL, K.M., TSOU, H.C., PEACOCKE, M., ENG, C. and PARSONS, R., Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature (Genet.), 16, 64-67 (1997).
13. MARKOV, G.G. and ARISON, V.J., Characteristics of nuclear-ribosomal and DNA-like ribonucleic acids differentially extracted by hot-phenol fractionation. Europ. J. Biochem., 35, 186-200 (1973).
14. MARSH, D.J., DAHIA, P.L., ZHENG, Z., LIAW, D., PARSON, R., GORLIN, R.J. and ENG, C., Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature (Genet.), 16, 333-334 (1997).
15. MAXWELL, G.L., RISINGER, J.I., GUMBS, C., SHAW, H., BENTLEY, R.C., BARRETT, J.C., BERCHUCK, A. and FUTREAL, P.A., Mutation of the PTEN tumor suppressor gene in endometrial hyperplasia. Cancer Res., 58, 2500-2503 (1998a).
16. MAXWELL, G.L., RISINGER, J.I., TONG, B., SHAW, H., BARRETT, J.C., BERCHUCK, A., and FUTREAL, P.A., Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers. Gynecol. Oncol., 70, 13-16 (1998b).
17. NORTON, P. A., Polypyrimidine tract sequence direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res., 22, 3854-3860 (1994).
18. OBATA, K., MORLAND, S.J., WATSON, R.H., HITCHCOCK, A., CHENEVIX-TRENCH, G., THOMAS, E.J. and CAMPBELL, I.G., Frequent PTEN/MMAC1 mutations in endometrial but not serous or mucinous epithelial ovarian tumors. Cancer Res., 58, 2095-2097 (1998).
19. OKAMOTO, A., SAMESHIMA, Y., YOKOYAMA, S., TERASHIMA, Y., SUGIYAMA, T., TERADA, M. and YOKOTA, J., Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res., 51, 5171-5176 (1991).
20. OLSCHWANG, S., SEROVA-SINILNIKOVA, O.M., LENOIR, G.M. and THOMAS, G., PTEN germ-line mutations in juvenile polyposis coli. Nature (Genet.), 18, 12-14 (1998).
21. OSBORNE, R.J. and LEECH, V., Polymerase chain reaction allelotyping of human ovarian cancer. Brit. J. Cancer, 69, 429-438 (1994).
22. RISINGER, J.I., HAYES, A.K., BERCHUCK, A. and BARRETT, J.C., PTEN/ MMAC1 mutation in endometrial cancers. Cancer Res., 57, 4736-4738 (1997).
23. ROSCIGNO, R.F., WEINER, M. and GARCIA-BLANCO, M.A., A mutational analysis of the polypyrimidine tract of introns. J. biol. Chem., 268, 11222-11229, (1993).
24. SAKURADA, A., SUZUKI, A., SATO, M., YAMAKAWA, H., ORIKASA, K., UYENO, S., ONO, T., OHUCHI, N., FUJIMURA, S. and HORII, A., Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn. J. Cancer Res., 88, 1025-1028 (1997).
25. SATO, T., SAITO, H., MORITA, R., KOI, S., LEE, J.H. and NAKAMURA, Y., Allelotype of human ovarian cancer. Cancer Res., 51, 5118-5122 (1991).
26. STECK, P.A. AND 14 OTHERS, Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature (Genet.), 15, 356-362 (1997).
27. TAMURA, M., GU, J., MATSUMOTO, K., AOTA, S., PARSONS, R. and YAMADA, K.M., Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-1617 (1998).
28. TASHIRO, H., BLAZES, M.S., WU, R., CHO, K.R., BOSE, S., WANF, S.I., LI, J., PARSONS, R. and ELLENSON, L.H., Mutation in PTEN are in endometrial carcinoma hut rare in other common gynecological malignancies. Cancer Res., 57, 3935-3940 (1997).
29. TENG, D. AND 28 OTHERS, MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57, 5221-5225 (1997).
30. WHANG, Y.E., WU, X., SUZUKI, H., REDER, R.E., TRAN, C., VESSELLA, R.L., SAID, J.W., ISAACS, W.B. and SAWYERS, C.L., Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. nat. Acad. Sci. (Wash.), 95, 5246-5250 (1998).
31. YOKOMIZO, A., TINDALL, D.J., HARTMANN, L., JENKINS, R.B., SMITH, D.I. and LIU, W., Mutation analysis of the putative tumor suppressor PTEN/ MMAC1 in human ovarian cancer. Int. J. Oncol., 13, 101-105 (1998).